Research on Epilepsy Treatment for Pediatric Patients among Most Cited in Medical Journal
October 21, 2014
Analysis Group Health Care consultants published research in the European Journal of Paediatric Neurology that was among the journal's top 20 most cited papers in the last year. The study, "Clinical Outcomes, Quality of Life, and Costs Associated with Implantation of vagus nerve stimulation Therapy in Pediatric Patients with Drug-Resistant Epilepsy" (September 2012, Volume 16, Issue 5), was conducted by an Analysis Group team including Managing Principal Mei Sheng Duh and Vice President Annie Guérin, along with researchers from Emory University School of Medicine and Cyberonics Inc.
The researchers conducted a retrospective analysis of Medicaid data to evaluate the long-term impact of vagus nerve stimulation (VNS) therapy implantation on health care resource utilization, epilepsy-related clinical events, direct health care costs, and quality-adjusted life years (QALY) in pediatric patients with drug-resistant epilepsy treated in a real-world setting. The study found that VNS implantation was associated with reduced numbers of hospitalizations, emergency room visits, and epilepsy-related events for pediatric patients, resulting in health care cost savings and QALY gain.
Read the abstract